Delivery Order SPE2DB24D9238-SPE2DB25FDRBH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml syringes. The contract, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- The Defense Logistics Agency issued a delivery order valued at $7,925.08 to DMS Pharmaceutical Group Inc. for EYLEA HD 8 mg/0.07 ml vials on July 25, 2025, with an ultimate completion date of August 15, 2025. EYLEA is a prescription pharmaceutical product used in the treatment of retinal diseases. This delivery order was issued under a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in...
- The Defense Logistics Agency awarded a $5,027.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml vials. The contract, with an ultimate completion date of September 25, 2025, was issued without set-aside designation, allowing DMS to compete on its merits as a small business in the federal pharmaceutical marketplace. This delivery order falls under DMS...
- On August 12, 2025, the Defense Logistics Agency awarded a delivery order valued at $5,943.78 to DMS Pharmaceutical Group Inc. for the supply of EYLEA HD 8 mg/0.07 ml vials. This firm fixed-price delivery order, issued without a set-aside designation, is scheduled for completion by September 3, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime contractor and sole awardee on...
- The Defense Logistics Agency (DLA) awarded a $11,887.62 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 mL vials. The award was issued on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order carries no set-aside designation, allowing the vendor to compete on a competitive basis. DMS Pharmaceutical Group will perform...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of EYLEA 2 mg/0.05 ml vials totaling $25,135.40. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml syringes valued at $9,778.40. The award was made on September 10, 2025, with an ultimate completion date of October 1, 2025, under a firm fixed-price delivery order contract with no set-aside designation. Performance will take place at the contractor's Park Ridge facility. This delivery...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $24,446.00 for EYLEA 2 mg/0.05 mL syringes. The award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a $2,513.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Eylea 2 mg/0.05 ml vials. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a specialized pharmaceutical procurement under DLA's broader pharmaceutical supply mission. This award carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on July 30, 2025, is scheduled for ultimate completion by August 20, 2025, with performance taking place in Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRBHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,540.68 to DMS Pharmaceutical Group Inc. for the supply of EYLEA 2 mg/0.05 mL vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, is for pharmaceutical products to be delivered to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime contractor and has been registered in the System for Award Management since 2001. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026. The parent contract enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support medical supply needs across Department of Defense healthcare facilities worldwide. EYLEA, an ophthalmic medication used to treat wet age-related macular degeneration and diabetic retinopathy, represents one of the specialized pharmaceutical products within DMS Pharmaceutical Group's extensive federal supply portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 9/15/25 |